DiscoverTwo Onc DocsASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer

ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer

Update: 2024-07-08
Share

Description

This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC). 


Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer

ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer